KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares Issued
Ratios

Jazz Pharmaceuticals (JAZZ) Shares Repurchased (2016 - 2024)

Historic Shares Repurchased for Jazz Pharmaceuticals (JAZZ) over the last 10 years, with Q3 2024 value amounting to $150.0 million.

  • Jazz Pharmaceuticals' Shares Repurchased rose 10169.29% to $150.0 million in Q3 2024 from the same period last year, while for Sep 2025 it was $249.8 million, marking a year-over-year decrease of 2294.22%. This contributed to the annual value of $311.4 million for FY2024, which is 1544.63% up from last year.
  • According to the latest figures from Q3 2024, Jazz Pharmaceuticals' Shares Repurchased is $150.0 million, which was up 10169.29% from $99.8 million recorded in Q4 2023.
  • Jazz Pharmaceuticals' 5-year Shares Repurchased high stood at $150.0 million for Q3 2024, and its period low was $7.5 million during Q2 2020.
  • For the 3-year period, Jazz Pharmaceuticals' Shares Repurchased averaged around $94.1 million, with its median value being $99.8 million (2023).
  • Its Shares Repurchased has fluctuated over the past 5 years, first plummeted by 8749.94% in 2020, then skyrocketed by 10169.29% in 2024.
  • Jazz Pharmaceuticals' Shares Repurchased (Quarter) stood at $7.5 million in 2020, then skyrocketed by 1233.44% to $99.8 million in 2023, then skyrocketed by 50.31% to $150.0 million in 2024.
  • Its Shares Repurchased stands at $150.0 million for Q3 2024, versus $99.8 million for Q4 2023 and $74.4 million for Q3 2023.